The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lubberts, E.
Right arrow Articles by van den Berg, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lubberts, E.
Right arrow Articles by van den Berg, W. B.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Joint Disorders
The Journal of Immunology, 2003, 170: 2655-2662.
Copyright © 2003 by The American Association of Immunologists

IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-{kappa}B Ligand/Osteoprotegerin Balance 1

Erik Lubberts2,*, Liduine van den Bersselaar*, Birgitte Oppers-Walgreen*, Paul Schwarzenberger{dagger}, Christina J. J. Coenen-de Roo{ddagger}, Jay K. Kolls{dagger}, Leo A. B. Joosten* and Wim B. van den Berg*

* Rheumatology and Advanced Therapeutics, University Medical Center Nijmegen, Nijmegen, The Netherlands; {dagger} Gene Therapy Program, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112; {ddagger} NV Organon, Oss, The Netherlands

IL-17 is a T cell-derived proinflammatory cytokine in experimental arthritis and is a stimulator of osteoclastogenesis in vitro. In this study, we report the effects of IL-17 overexpression (AdIL-17) in the knee joint of type II collagen-immunized mice on bone erosion and synovial receptor activator of NF-{kappa}B ligand (RANKL)/receptor activator of NF-{kappa}B/osteoprotegerin (OPG) expression. Local IL-17 promoted osteoclastic bone destruction, which was accompanied with marked tartrate-resistant acid phosphatase activity at sites of bone erosion in cortical, subchondral, and trabecular bone. Accelerated expression of RANKL and its receptor, receptor activator of NF-{kappa}B, was found in the synovial infiltrate and at sites of focal bone erosion, using specific immunohistochemistry. Interestingly, AdIL-17 not only enhanced RANKL expression but also strongly up-regulated the RANKL/OPG ratio in the synovium. Comparison of arthritic mice from the AdIL-17 collagen-induced arthritis group with full-blown collagen-arthritic mice having similar clinical scores for joint inflammation revealed lower RANKL/OPG ratio and tartrate-resistant acid phosphatase activity in the latter group. Interestingly, systemic OPG treatment prevented joint damage induced by local AdIL-17 gene transfer in type II collagen-immunized mice. These findings suggest T cell IL-17 to be an important inducer of RANKL expression leading to loss of the RANKL/OPG balance, stimulating osteoclastogenesis and bone erosion in arthritis.




This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
S. W. SYVERSEN, R. LANDEWE, D. van der HEIJDE, J. M. BATHON, M. BOERS, V. P. BYKERK, O. FITZGERALD, D. D. GLADMAN, P. GARNERO, P. GEUSENS, et al.
Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in Rheumatoid Arthritis: A Systematic Literature Search on 5 Candidate Biomarkers
J Rheumatol, August 1, 2009; 36(8): 1769 - 1784.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Nistala and L. R. Wedderburn
Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis
Rheumatology, June 1, 2009; 48(6): 602 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Kiesel, Z. S. Buchwald, and R. Aurora
Cross-Presentation by Osteoclasts Induces FoxP3 in CD8+ T Cells
J. Immunol., May 1, 2009; 182(9): 5477 - 5487.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. D. Doodes, Y. Cao, K. M. Hamel, Y. Wang, B. Farkas, Y. Iwakura, and A. Finnegan
Development of Proteoglycan-Induced Arthritis Is Independent of IL-17
J. Immunol., July 1, 2008; 181(1): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. S. H. Gaston
Cytokines in arthritis the 'big numbers' move centre stage
Rheumatology, January 1, 2008; 47(1): 8 - 12.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Yamaguchi, K. Fujio, H. Shoda, A. Okamoto, N. H. Tsuno, K. Takahashi, and K. Yamamoto
IL-17B and IL-17C Are Associated with TNF-{alpha} Production and Contribute to the Exacerbation of Inflammatory Arthritis
J. Immunol., November 15, 2007; 179(10): 7128 - 7136.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G. Schett
Joint remodelling in inflammatory disease
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii42 - iii44.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Munroe, J. L. Arbiser, and G. A. Bishop
Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis
J. Immunol., July 15, 2007; 179(2): 753 - 763.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Maitra, F. Shen, W. Hanel, K. Mossman, J. Tocker, D. Swart, and S. L. Gaffen
Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression
PNAS, May 1, 2007; 104(18): 7506 - 7511.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. R. Pettit, N. C. Walsh, C. Manning, S. R. Goldring, and E. M. Gravallese
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis
Rheumatology, September 1, 2006; 45(9): 1068 - 1076.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Lubberts, P. Schwarzenberger, W. Huang, J. R. Schurr, J. J. Peschon, W. B. van den Berg, and J. K. Kolls
Requirement of IL-17 Receptor Signaling in Radiation-Resistant Cells in the Joint for Full Progression of Destructive Synovitis
J. Immunol., September 1, 2005; 175(5): 3360 - 3368.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Shen, M. J. Ruddy, P. Plamondon, and S. L. Gaffen
Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-{alpha}-induced genes in bone cells
J. Leukoc. Biol., March 1, 2005; 77(3): 388 - 399.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
Y. Kishimoto, S. Fukumoto, S. Nishihara, H. Mizumura, K. Hirai, and R. Teshima
Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis
Rheumatology, December 1, 2004; 43(12): 1496 - 1503.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. C. Hofbauer and M. Schoppet
Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases
JAMA, July 28, 2004; 292(4): 490 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Ruddy, G. C. Wong, X. K. Liu, H. Yamamoto, S. Kasayama, K. L. Kirkwood, and S. L. Gaffen
Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-{alpha} Is Mediated by CCAAT/Enhancer-binding Protein Family Members
J. Biol. Chem., January 23, 2004; 279(4): 2559 - 2567.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.